Evidence and Analysis
edited by Peter McCulloch
Gastrointestinal Oncology covers best practices for the management of patients with cancers of the esophagus, stomach, colon, liver, and pancreas.
Focusing on a wide variety of gastrointestinal carcinomas by organ and tumor type, this source provides expert coverage of diagnostic, staging, and treatment procedures by seasoned oncologists and radiologists, and offers in-depth discussions of current research regarding tumor markers, molecular biology, and clinical presentation.
Features:
- spans the existing evidence from experienced opinion leaders in the field of gastrointestinal oncology
- pairs organ-based chapters so that surgical and non-surgical oncologists provide perspectives on the same condition
- supplies an up-to-date and relevant summary of the key topics in gastrointestinal oncology, supported by clear scientific evidence
- combines surgical and medical approaches to cancers in specific organs, supplying a rigorous evidence-based approach to the evaluation of various treatments
- addresses critical topics in the area including the management and prevention of cancers around the gastro-oesophageal junction, rectal cancer, and gastro-intestinal stromal tumors
- considers the latest developments in surgical, radiation, and chemotherapeutic management
Contents
- Surgical and Ablative Treatment of Barrett's Oesophagus and It's Complications
- Oesophageal Cancer: Chemotherapy and Radiotherapy
- Surgical Treatment of Oesophageal Carcinoma
- Chemotherapy for Metastatic Colorectal Cancer
- Adjuvant Therapy for Colorectal Cancer
- Chemotherapy and Radiotherapy for the Treatment of Hepatocellular Carcinoma
- Surgical Management of Hepatocellular Carcinoma
- The Role of Radiotherapy in the Management of Rectal Carcinoma
- Carcinoid Tumours
- Carcinoid Syndrome
- Surgical Treatment of Carcinomas Involving the Oesophagogastric Junction
- The Role of Drugs and Nutrition in the Prevention of Oesophageal Adenocarcinoma Associated with Barrett's Oesophagus
- Gastrointestinal Lymphomas. Cancer of the Bile Ducts and Gall Bladder
Index